SCHEMBL4899503

SCHEMBL4899503

COc1ccc(CN(Cc2ccc(OC)cc2)CC(Cc2ccccc2)Nc2ncc(-c3ccc4cnccc4c3)n2COCC[Si](C)(C)C)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 4/20 0.37
DGAT1 O75907 1/20 0.35
CYP3A4 P08684 1/20 0.33
F11 P03951 1/20 0.33
GAA P10253 1/20 0.33
ATP1A1 P05023 1/20 0.33
ATP1B1 P05026 1/20 0.33
ATP1A3 P13637 1/20 0.33
ATP1B2 P14415 1/20 0.33
ATP1A2 P50993 1/20 0.33
ATP1B3 P54709 1/20 0.33
FXYD2 P54710 1/20 0.33
ATP1A4 Q13733 1/20 0.33
NR1H3 Q13133 2/20 0.32
CCNE1 P24864 2/20 0.32
CDK2 P24941 2/20 0.32
CDC7 O00311 1/20 0.32
DBF4 Q9UBU7 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
CYP19A1 P11511 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895976 0.68 AKT1 (0.38) AKT1DGAT1CCNE1CDK2CDC7
SCHEMBL12766311 0.65 AKT1 (0.51) AKT1GAAATP1A1ATP1B1ATP1A3
SCHEMBL12766310 0.61 HDAC8 (0.44) GAA
SCHEMBL12766324 0.61 AKT1 (0.46) AKT1CYP3A4GAACDK2
SCHEMBL4779887 0.60 AKT1 (0.49) AKT1CCNE1CDK2CDC7DBF4
SCHEMBL12766349 0.60 AKT1 (0.51) AKT1CDK2
SCHEMBL4796693 0.60 ROCK1 (0.50) AKT1CYP3A4CCNE1CDK2CDC7
SCHEMBL1794846 0.60 DGAT1 (0.37) DGAT1NR1H3CYP19A1
SCHEMBL12766197 0.60 AKT1 (0.46) AKT1CYP3A4CDK2
SCHEMBL12766199 0.59 AKT1 (0.48) AKT1CYP3A4CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith D SIDOCKY NEIL R 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith JAK2, CHEK2, MTOR AKT1 26/4885DGAT1 3541/4885CYP3A4 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.